Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

sargramostim 2Topotecan 2timcodar 1bempegaldesleukin 1Tissue Plasminogen Activator 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Muromonab-CD3 1Irinotecan 1Interferon-alpha 1Immunization, Passive 1Gemcitabine 1Docetaxel 1Diathermy 1Cyclophosphamide 1Cisplatin 1Captopril 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Unspecified Adult Solid Tumor, Protocol Specific × timcodar × Clear all
NCT00004030 2011-03-24

VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin

Georgetown University

Phase 1/2 Completed
45 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡